Thus, STn expression in cancer is most probably due to over-expression of ST6GalNAc I, with enhancing effects of increased synthesis of precursors (i.e., increased transfer of O-GalNAc) and decreased competition (i.e., decreased core-synthesis). The gene discussed is EEF1A2; the disease is cancer.